Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population

BACKGROUND: Diabetes mellitus (DM) is a chronic disease that needs early management to prevent complications and premature mortality. Therefore, it is essential to select evidence-based drugs available to control diabetes and limit the progression to related complications. This study aimed to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Asima, Khan, Izhan A., Abidi, Hussain, Ahmed, Mansoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428695/
https://www.ncbi.nlm.nih.gov/pubmed/36060955
http://dx.doi.org/10.3389/fendo.2022.926633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428695/
https://www.ncbi.nlm.nih.gov/pubmed/36060955
http://dx.doi.org/10.3389/fendo.2022.926633

Ejemplares similares